Industry News
Hansa Biopharma signals sharp shift in strategy
Hansa Biopharma is set to cut 20% of its workforce as part of a sweeping restructure aimed at streamlining operations and sharpening its focus. Under new leadership, the company plans to unlock SEK 40–50 million in annual savings by reallocating resources and increasing organisational efficiency. The move reflects a growing trend among biotech firms to recalibrate amid mounting cost pressures and the demand for greater shareholder returns.
Read the full story for insight into what’s driving the shake-up.
Discover What's Happening
Business Sustainability Updates, Straight to Your Inbox
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
